Antiviral drug molnupiravir linked to SARS-CoV-2 mutations

Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town and UKHSA have uncovered a link between an antiviral drug for COVID-19 ...


New strategies reduce treatment failure in malaria by up to 81%

Artemisinin-based combination therapies (ACTs) are the globally-accepted first-line treatments for malaria—a mosquito-borne disease caused by the Plasmodium falciparum parasite that annually kills around 600,000 people, ...


Combining potent cancer drugs in a single multitargeting molecule

To give cancer treatments the greatest possible chance of success, patients are often treated with multiple drugs that attack the cancer using different mechanisms. A team of researchers has now combined three highly potent ...

page 1 from 14